Literature DB >> 12551996

B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.

Michael S Diamond1, Bimmi Shrestha, Anantha Marri, Darby Mahan, Michael Engle.   

Abstract

West Nile virus (WNV) causes severe central nervous system (CNS) infection primarily in humans who are immunocompromised or elderly. In this study, we addressed the mechanism by which the immune system limits dissemination of WNV infection by infecting wild-type and immunodeficient inbred C57BL/6J mice with a low-passage WNV isolate from the recent epidemic in New York state. Wild-type mice replicated virus extraneuronally in the draining lymph nodes and spleen during the first 4 days of infection. Subsequently, virus spread to the spinal cord and the brain at virtually the same time. Congenic mice that were genetically deficient in B cells and antibody (microMT mice) developed increased CNS viral burdens and were vulnerable to lethal infection at low doses of virus. Notably, an approximately 500-fold difference in serum viral load was detected in micro MT mice as early as 4 days after infection, a point in the infection when low levels of neutralizing immunoglobulin M antibody were detected in wild-type mice. Passive transfer of heat-inactivated serum from infected and immune wild-type mice protected micro MT mice against morbidity and mortality. We conclude that antibodies and B cells play a critical early role in the defense against disseminated infection by WNV.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12551996      PMCID: PMC141119          DOI: 10.1128/jvi.77.4.2578-2586.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

Review 1.  Natural antibodies and complement link innate and acquired immunity.

Authors:  A F Ochsenbein; R M Zinkernagel
Journal:  Immunol Today       Date:  2000-12

Review 2.  Role of antibodies in controlling alphavirus infection of neurons.

Authors:  D E Griffin; S Ubol; P Desprès; T Kimura; A Byrnes
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

3.  Impaired T cell immunity in B cell-deficient mice following viral central nervous system infection.

Authors:  C C Bergmann; C Ramakrishna; M Kornacki; S A Stohlman
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

4.  Long term intraparenchymal Ig secretion after acute viral encephalitis in mice.

Authors:  W R Tyor; S Wesselingh; B Levine; D E Griffin
Journal:  J Immunol       Date:  1992-12-15       Impact factor: 5.422

Review 5.  The immune response in viral encephalitis.

Authors:  D E Griffin; B Levine; W R Tyor; D N Irani
Journal:  Semin Immunol       Date:  1992-04       Impact factor: 11.130

Review 6.  CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire.

Authors:  P Casali; A L Notkins
Journal:  Immunol Today       Date:  1989-11

7.  Rapid detection of west nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay.

Authors:  R S Lanciotti; A J Kerst; R S Nasci; M S Godsey; C J Mitchell; H M Savage; N Komar; N A Panella; B C Allen; K E Volpe; B S Davis; J T Roehrig
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

8.  Antibody-mediated clearance of alphavirus infection from neurons.

Authors:  B Levine; J M Hardwick; B D Trapp; T O Crawford; R C Bollinger; D E Griffin
Journal:  Science       Date:  1991-11-08       Impact factor: 47.728

Review 9.  The effect of age on the B-cell repertoire.

Authors:  M E Weksler; P Szabo
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.542

10.  B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection.

Authors:  N Baumgarth; O C Herman; G C Jager; L E Brown; L A Herzenberg; J Chen
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

View more
  240 in total

Review 1.  West Nile virus: a growing concern?

Authors:  L Hannah Gould; Erol Fikrig
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

2.  A short N-terminal peptide motif on flavivirus nonstructural protein NS1 modulates cellular targeting and immune recognition.

Authors:  Soonjeon Youn; Hyelim Cho; Daved H Fremont; Michael S Diamond
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

Review 3.  Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex.

Authors:  Mario Lobigs; Michael S Diamond
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

Review 4.  West Nile Virus: biology, transmission, and human infection.

Authors:  Tonya M Colpitts; Michael J Conway; Ruth R Montgomery; Erol Fikrig
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

5.  Identification of novel small-molecule inhibitors of West Nile virus infection.

Authors:  Amine O Noueiry; Paul D Olivo; Urszula Slomczynska; Yi Zhou; Ben Buscher; Brian Geiss; Michael Engle; Robert M Roth; Kyung Min Chung; Melanie Samuel; Michael S Diamond
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

6.  Induction of epitope-specific neutralizing antibodies against West Nile virus.

Authors:  Theodore Oliphant; Grant E Nybakken; S Kyle Austin; Qing Xu; Jonathan Bramson; Mark Loeb; Mark Throsby; Daved H Fremont; Theodore C Pierson; Michael S Diamond
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

Review 7.  West Nile virus infection and immunity.

Authors:  Mehul S Suthar; Michael S Diamond; Michael Gale
Journal:  Nat Rev Microbiol       Date:  2013-02       Impact factor: 60.633

8.  Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis.

Authors:  Robyn S Klein; Eugene Lin; Bo Zhang; Andrew D Luster; Judy Tollett; Melanie A Samuel; Michael Engle; Michael S Diamond
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal West Nile virus infection in aged mice.

Authors:  Amelia K Pinto; Justin M Richner; Elizabeth A Poore; Pradnya P Patil; Ian J Amanna; Mark K Slifka; Michael S Diamond
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

10.  Oral administration of active hexose correlated compound enhances host resistance to West Nile encephalitis in mice.

Authors:  Shuhui Wang; Thomas Welte; Hao Fang; Gwong-Jen J Chang; Willi K Born; Rebecca L O'Brien; Buxiang Sun; Hajime Fujii; Ken-ichi Kosuna; Tian Wang
Journal:  J Nutr       Date:  2009-01-13       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.